Determination of Methotrexate in pH-Sensitive Chitosan Nanoparticles by Validated RP-LC and UV Spectrophotometric Methods

dc.contributor.author
Nogueira, Daniele R.
dc.contributor.author
Macedo, Letícia B.
dc.contributor.author
Scheeren, Laís E.
dc.contributor.author
Mitjans Arnal, Montserrat
dc.contributor.author
Infante Martínez-Pardo, Ma. Rosa
dc.contributor.author
Rolim, Clarice M. B.
dc.contributor.author
Vinardell Martínez-Hidalgo, Ma. Pilar
dc.date.issued
2016-04-08T17:17:42Z
dc.date.issued
2016-04-08T17:17:42Z
dc.date.issued
2014-12
dc.date.issued
2016-04-08T17:17:47Z
dc.identifier
2309-4435
dc.identifier
https://hdl.handle.net/2445/97209
dc.identifier
644826
dc.description.abstract
Nanotechnology-based drug delivery systems are in constant development and, therefore, it is of great importance to have rapid, efficient and accurate analytical methodology to quantify the encapsulated drugs. Here, simple and fast methods, by reversed-phase liquid chromatography (RP-LC) and UV spectrophotometry, were developed and validated for the determination of methotrexate (MTX) in pH-sensitive chitosan nanoparticles (CS-NPs). NPs were prepared using a modified ionotropic complexation process, in which was included a surfactant derived from Nα,Nε-dioctanoyl lysine with an inorganic sodium counterion. The RP-LC method was carried out on a Waters XBridgeTM C18 column (250 mm x 4.6 mm I.D., 5μm), with mobile phase consisted of potassium phosphate buffer (0.05 M, pH 3.2): acetonitrile (86:14, v/v), and UV detection set at 303 nm. The analyses of MTX content by the UV method were also accomplished at 303 nm, using 0.1 M sodium hydroxide as diluent. The measurements were linearly correlated with concentration for both methods in the 1 - 30 μg/mL range (r > 0.9999). The specificity tests showed that there was no interference of the NP components on the quantitative analyses. Precision (repeatability and intermediate precision) was demonstrated by a relative standard deviation lower than 1.5%, whereas the accuracy was assessed by the recovery of MTX from sample matrices, given mean value of ~99%. The proposed methods were applied for the analyses of MTX in different batches of NPs, and the results showed non-significant differences (p > 0.05) between the values obtained with both methodologies. Moreover, the RP-LC method was successfully used to determine the drug entrapment efficiency, and to quantify MTX during in vitro release assays and photolytic degradation studies. In conclusion, the validated methods are suitable to assay MTX in pH-sensitive CS-NPs without any interference from the polymer or surfactant.
dc.format
9 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
Pharma Publisher
dc.relation
Reproducció del document publicat a: http://dx.doi.org/10.14205/2309-4435.2014.02.02.3
dc.relation
Journal of Applied Biopharmaceutics and Pharmacokinetics , 2014, vol. 2, num. 2, p. 59-67
dc.relation
http://dx.doi.org/10.14205/2309-4435.2014.02.02.3
dc.rights
cc-by-nc (c) Nogueira D.R. et al., 2014
dc.rights
http://creativecommons.org/licenses/by-nc/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Bioquímica i Fisiologia)
dc.subject
Quitosan
dc.subject
Nanopartícules
dc.subject
Medicaments antineoplàstics
dc.subject
Metotrexat
dc.subject
Agents tensioactius
dc.subject
Cromatografia
dc.subject
Espectroscòpia
dc.subject
Chitosan
dc.subject
Nanoparticles
dc.subject
Antineoplastic agents
dc.subject
Methotrexate
dc.subject
Surface active agents
dc.subject
Chromatography
dc.subject
Spectrum analysis
dc.title
Determination of Methotrexate in pH-Sensitive Chitosan Nanoparticles by Validated RP-LC and UV Spectrophotometric Methods
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)